Ovid Therapeutics, Inc. (OVID)
2.40
-0.10
(-3.81%)
USD |
NASDAQ |
Sep 25, 16:00
2.41
+0.01
(+0.42%)
After-Hours: 19:59
Ovid Therapeutics Price : 2.40 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | 2.49 | 2.51 | 2.40 | 2.40 | 1.365M |
| Sep 24, 2026 | 2.54 | 2.54 | 2.405 | 2.495 | 1.528M |
| Sep 23, 2026 | 2.75 | 2.75 | 2.44 | 2.57 | 2.635M |
| Sep 22, 2026 | 2.76 | 2.845 | 2.714 | 2.76 | 3.744M |
| Sep 21, 2026 | 2.73 | 2.76 | 2.65 | 2.71 | 1.184M |
| Sep 18, 2026 | 2.68 | 2.73 | 2.63 | 2.69 | 5.899M |
| Sep 17, 2026 | 2.73 | 2.77 | 2.66 | 2.70 | 1.986M |
| Sep 16, 2026 | 2.72 | 2.765 | 2.65 | 2.68 | 1.428M |
| Sep 15, 2026 | 2.73 | 2.745 | 2.63 | 2.71 | 988551.0 |
| Sep 14, 2026 | 2.755 | 2.795 | 2.690 | 2.74 | 1.200M |
| Sep 11, 2026 | 2.73 | 2.73 | 2.64 | 2.69 | 1.148M |
| Sep 10, 2026 | 2.68 | 2.70 | 2.61 | 2.63 | 1.404M |
| Sep 09, 2026 | 2.74 | 2.781 | 2.685 | 2.70 | 1.264M |
| Sep 08, 2026 | 2.75 | 2.81 | 2.73 | 2.75 | 1.151M |
| Sep 04, 2026 | 2.74 | 2.825 | 2.71 | 2.80 | 1.066M |
| Sep 03, 2026 | 2.80 | 2.83 | 2.73 | 2.78 | 1.362M |
| Sep 02, 2026 | 2.78 | 2.87 | 2.68 | 2.71 | 1.556M |
| Sep 01, 2026 | 2.65 | 2.78 | 2.64 | 2.76 | 1.295M |
| Aug 31, 2026 | 2.78 | 2.805 | 2.65 | 2.67 | 1.393M |
| Aug 28, 2026 | 2.87 | 2.93 | 2.76 | 2.80 | 1.674M |
| Aug 27, 2026 | 2.85 | 2.95 | 2.83 | 2.93 | 1.723M |
| Aug 26, 2026 | 2.905 | 2.93 | 2.845 | 2.88 | 1.143M |
| Aug 25, 2026 | 2.85 | 2.94 | 2.815 | 2.91 | 1.450M |
| Aug 24, 2026 | 2.79 | 2.86 | 2.67 | 2.82 | 1.230M |
| Aug 21, 2026 | 2.76 | 2.83 | 2.71 | 2.80 | 1.332M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.68 |
| Alnylam Pharmaceuticals, Inc. | 255.96 |
| Anika Therapeutics, Inc. | 20.37 |
| Savara, Inc. | 5.00 |
| Vericel Corp. | 39.71 |
Price Related Metrics
| PS Ratio | 184.36 |
| Price to Book Value | 2.113 |
| Earnings Yield | -10.56% |
| Market Cap | 443.41M |